TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression

被引:20
作者
Bulwin, Grit-Carsta
Heinemann, Thomas
Bugge, Volker
Winter, Michael
Lohan, Anke
Schlawinsky, Mirko
Schulze, Anke
Waelter, Stephanie
Sabat, Robert
Schuelein, Ralf
Wiesner, Burkhard
Veh, Ruediger W.
Loehler, Juergen
Blumberg, Richard S.
Volk, Hans-Dieter
Utku, Nalan
机构
[1] Humboldt Univ, Inst Med Immunol, D-10115 Berlin, Germany
[2] GenPat77 Pharmacogenet, Berlin, Germany
[3] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-5300 Bonn, Germany
[4] Forsch Inst Mol Pharmakol, Berlin, Germany
[5] Humboldt Univ, Anatom Inst, Berlin, Germany
[6] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Mol Pathol Grp, D-2000 Hamburg, Germany
[7] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.177.10.6833
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ab targeting of TIRC7 has been shown previously to inhibit T cell proliferation and Th1 lymphocyte-associated cytokine production. In this study, we demonstrate that Ab targeting of TIRC7 induces early cell surface expression of CTLA-4. The majority of stimulated CD4(+) and CD8(+) human T cells coexpress CTLA-4 and TIRC7. Similar to CTLA-4, TIRC7 rapidly accumulates at the site of Ag adhesion upon T cell activation. TIRC7 seems to colocalize with CTLA-4 in human T cells, and both molecules are associated with clathrin-coated vesicles, indicating they share intracellular transport systems. Moreover, Ab targeting of TIRC7 results in an early activation of CTLA-4 transcription. The inhibition of cell proliferation mediated by TIRC7 is dependent on CTLA-4 expression because the TIRC7-mediated inhibitory effects on cell proliferation and cytokine expression are abolished by Ab blockade of CTLA-4. Splenocytes obtained from CTLA-4-deficient mice are not responsive to TIRC7 Ab targeting. Thus, TIRC7 acts as an upstream regulatory molecule of CTLA-4 expression.
引用
收藏
页码:6833 / 6841
页数:9
相关论文
共 44 条
[1]  
Alegre ML, 1998, J IMMUNOL, V161, P3347
[2]   The immunological synapse [J].
Bromley, SK ;
Burack, WR ;
Johnson, KG ;
Somersalo, K ;
Sims, TN ;
Sumen, C ;
Davis, MM ;
Shaw, AS ;
Allen, PM ;
Dustin, ML .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :375-396
[3]   T cell antigen receptor signal transduction pathways [J].
Cantrell, D .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :259-274
[4]   CTLA-4 is important in maintaining long-term survival of cardiac allografts [J].
Chandraker, A ;
Huurman, V ;
Hallett, K ;
Yuan, XL ;
Tector, AJ ;
Park, CH ;
Lu, E ;
Zavazava, N ;
Oaks, M .
TRANSPLANTATION, 2005, 79 (08) :897-903
[5]  
Chuang E, 1997, J IMMUNOL, V159, P144
[6]   CONTINGENT GENETIC REGULATORY EVENTS IN LYMPHOCYTE-T ACTIVATION [J].
CRABTREE, GR .
SCIENCE, 1989, 243 (4889) :355-361
[7]   Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength [J].
Egen, JG ;
Allison, JP .
IMMUNITY, 2002, 16 (01) :23-35
[8]   CTLA-4 up-regulation plays a role in tolerance mediated by CD45 [J].
Fecteau, S ;
Basadonna, GP ;
Freitas, A ;
Ariyan, C ;
Sayegh, MH ;
Rothstein, DM .
NATURE IMMUNOLOGY, 2001, 2 (01) :58-63
[9]   Study of the interaction of the medium chain μ2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28 [J].
Follows, ER ;
McPheat, JC ;
Minshull, C ;
Moore, NC ;
Pauptit, RA ;
Rowsell, S ;
Stacey, CL ;
Stanway, JJ ;
Taylor, IWF ;
Abbott, WM .
BIOCHEMICAL JOURNAL, 2001, 359 (02) :427-434
[10]   Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition [J].
Genovese, MC ;
Becker, J ;
Schiff, M ;
Luggen, M ;
Sherrer, Y ;
Kremer, J ;
Birbara, C ;
Box, J ;
Natarajan, K ;
Nuamah, I ;
Li, T ;
Aranda, R ;
Hagerty, DT ;
Dougados, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (11) :1114-1123